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Abstract 
  Computer Vision for automated analysis of cells and tissues usually include extracting features 
from images before analyzing such features via various Machine Learning and Machine Vision 
algorithms. We developed a Convolutional Neural Network model that classifies MDA-MB-468 
and MCF7 breast cancer cells via brightfield microscopy images without the need of any prior 
feature extraction. Our 6-layer Convolutional Neural Network is directly trained, validated and 
tested on 1,241 images of MDA-MB-468 and MCF7 breast cancer cell line in an end-to-end 
fashion, allowing a system to distinguish between different cancer cell types. The model takes 
in as input imaged breast cancer cell line and then outputs the cell line type (MDA-MB-468 or 
MCF7) as predicted probabilities between the two classes. Our model scored a 99% Accuracy.  
  
Introduction 
  Convolutional Neural Networks were developed initially in the 1980s and were called 
Neocognitron (Fukushima, 1980, 1983, 1987).  They are broadly part of a wide set of models 
called Multi-Stage Hubel-Wiesel Architectures. In 1989, LeNet-5 was introduced which simplified 
the architecture and used the Backpropagation algorithm to train the entire architecture in a 
supervised fashion (Yann LeCun, 1989). The architecture was successful for tasks such as Optical 
Character Recognition and Handwriting Recognition. Convolutional Neural Networks have been 
an important aspect of Deep Learning in recent years. They were mainly responsible for the re-
emergence and popularity of Neural Networks. The work of Alex Krizhevsky and Ilya Sutskever 
which won the ImageNet Large Scale Visual Recognition Competition in 2012 (ILSVRC-2012) was 
disruptive in the Artificial Intelligence, Machine Learning and Computer Vision community (Alex 
Krizhevsky et al., 2012). Since then Convolutional Neural Networks have been heavily applied to 
all sorts of problems, from various Object Detection and Image Segmentation problems (Liang-
Chieh Chen  et al., 2014,  J. Redmon et al., 2015,   S. Ren et al., 2015 ) and to specific domains like 
Medical Image Analysis (Shadi Albarqouni et al., 2016,   Mark J. J. P. van Grinsven  et al., 2016,  
Lin Yang et al., 2017, Andre Esteva  et al., 2017).  
   
  Their effectiveness can be attributed to their ability to handle translation invariances in images 
by relying on shared weights and exploit spatial locality by enforcing a local connectivity pattern 
between neurons of adjacent layers. We chose them for this reason, knowing we wanted a model 
that could visually detect and differentiate between different breast cancer cell lines such as 
MDA-MB-468 and MCF7 in an end-to-end fashion. According to the American Cancer Society, 
breast cancer is the leading diagnosed cancer for American women, not including skin cancer, 
with more than 250,000 new cases of invasive cases expected and more than 40,000 deaths as 
of 2017, making it an important target to address stateside (DeSantis et al 2017).  This is especially 
the case in developing regions abroad, where care is less accessible, especially due to a lack of 
sophisticated equipment, reagents, and more may hinder detection.  In efforts to diagnose and 
treat cancer, tools that can assist less equipped labs are increasingly important. Within, we 
present a tool that can distinguish between images of cell lines via brightfield microscopy, 
without additional preparation, that may assist automated detection tools and diagnoses. 
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Figure 1. Samples of MDA-MB-468 and MCF7 breast cancer cell that were used in training the 
Convolutional Neural Network. 
 
Data  
  We used a collection of 1,241 grayscale images of MDA-MB-468 and MCF7 breast cancer cell for 
training, validation and testing our model. Sample images from the dataset can be seen in Figure 
1 above. Our dataset contains 664 MDA-MB-468 breast cancer cell images and 577 MCF7 breast 
cancer cell as shown in Figure 2 below. MDA-MB-468 cells and MCF7 cells were cultured and then 
placed into 3 separate 6-well cell plates and imaged at 400X via brightfield microscopy. Images 
were separated into brightly and dimly lit categories and then tiled into 128 x 128 pixel images 
for analysis. Given the broadness of the wells and cell positions imaged, lighting differed, adding 
a challenge to the process, which can reflect practical research realities and variations, leading 
to difficulty in automated systems properly detecting cells. 
 
  The dataset was split into Training set, Validation set and Testing set with a 8:1:1 ratio (995, 
123, 123), respectively. The dimensions of all the images were reshaped to 128 by 128 pixels. The 
images were then transformed by Standardization so our image pixel values that’d act as inputs 
to our model would have a similar range for more stable gradients during training. To increase 
the variation in our dataset to ensure our trained model generalizes beyond its training data. We 
further augmented the images with random horizontal flips, 5° rotations, width shifts, height 
shifts and zooms. 
 
 
Figure 3. The complete dataset contains 664 MDA-MB-468 breast cancer cell images and 577 
MCF7 breast cancer cells. 
 
 
Figure 4. The architecture of our Convolutional Neural Network. Based on the ScaffoldNet 
architecture. The model propagates the input image through its 4 hidden layers and then 
outputs predicted probabilities between 0 and 1, represent both MDA-MB-468 and MCF7 
classes respectively, with the threshold being 0.5. This example accurately outputs 0.01, which 
represents MDA-MB-468 cell class. 
 
Model Architecture 
  We use a 6-layer Convolutional Neural Network trained and tested on 1,241 grayscale images 
of MDA-MB-468 and MCF7 breast cancer cells. Our Convolutional Neural Network architecture 
is based on the ScaffoldNet architecture (Akogo DA and Palmer XL., 2018). As shown in Figure 4, 
our network ScaffoldNet starts with two 2-Dimensional Convolutional layers with a 3 x 3 kernel 
size and 32 output filters with the first as its input layer. Then followed by a single 2-Dimensional 
Convolutional layers also with a 3 x 3 kernel size and 64 output filters.  
We then introduce a 2-Dimensional Global Average Pooling layer to reduce the spatial 
dimensions of our tensor (Min Lin et al., 2013). Global Average Pooling performs Dimensionality 
Reduction to minimize overfitting by turning a tensor with dimensions h × w × d into 1 × 1 × d 
which is achieved by reducing each h × w  feature map to a single number simply by taking the 
average of all hw values. To further prevent overfitting, we then add a Dropout Regularizer with 
a fraction rate of 0.5 (Srivastava et al., 2014). And then we introduce a 32 unit densely-connected 
Neural Network layer into our network architecture, followed by another Dropout Regularizer 
with a 0.5 fraction rate. Our final output layer is a single unit dense Neural Network layer.  
 
  All Convolutional and Densely-connected layers except the output layer use the Rectified Linear 
Unit (RELU) activation function:   
f(x) = max(0, x)  
 
where x is the input to a neuron (Hahnloser et al., 2000).  
 
The final single neuron output layer uses a Sigmoid activation function:  
  
where  x  is the input to a neuron and e is the natural logarithm base (also known as Euler's 
number) 
 
   Our Convolutional Neural Network is trained end-to-end with the first-order gradient-based 
optimization algorithm, Adam, using the standard parameters(β1 = 0:9 and β2 = 0:999)   
(Kingma and Ba, 2014). And we use the Cross-Entropy loss function for Binary Classification: 
 
−(y log(p) + ( 1 − y ) log(1 − p)) 
 
  where  log - the natural log 
y - binary indicator (0 or 1) if class label c is the correct classification for observation o 
p - predicted probability observation 
 
We train our model using mini-batches of 32. We use a learning rate(α) of 0.001, and pick the 
model with the lowest validation loss. 
 
Model Training and Validation 
 Using the Training set (995 images), our Convolutional Neural Network was trained with Adam 
optimization algorithm. Cross-Entropy loss function and the Accuracy Classification Score were 
used as metrics. The Accuracy score formula is;  
 
 
        where the   is the predicted output for i -th sample   is the (correct) target output 
computed over   
 
  Our model was trained in 8 epochs and its hyperparameters tuned using the Validation set (123 
images). After just the first epoch, our model had the following performance results on the 
Validation set; 
Accuracy score: 94.31% 
Cross-Entropy loss: 0.1801 
 
After the 8th epoch, our model’s final performance results on the Validation set were; 
Accuracy score: 98.37% 
Cross-Entropy loss: 0.0934 
 
 
Model Testing and Results 
  After all training and validation, we finally evaluated our model on the Test set (123 images). 
The Test set is the final evaluation for a model and changes are not made to the model after the 
results.  
 
ScaffoldNet’s final performance results on the Test set were; 
 
Accuracy score:  99.00% 
Cross-Entropy loss: 0.0926 
 
  From the results of the final evaluation, we can tell that our model generalizes well and doesn’t 
overfit, the high accuracy performance on the Validation set is consistent with the evaluation 
results on the Test set.  
 
  To further evaluate our Convolutional Neural Network’s output quality, we use the Receiver 
Operating Characteristic (ROC) metric and its Area Under Curve (AUC) score. We use the ROC 
curve to plot our model’s true positive rate on the Y axis, and false positive rate on the X axis. 
Our Convolutional Neural Network classifier has a near perfect AUC score of 0.98 as shown in the 
plot below, in Figure 4. 
 
 
Figure 4. As seen on the curve, our Convolutional Neural Network Classifier has a high AUROC 
score of 0.98. 
 
Related Work 
  Some earlier works exist within the domain of Computer Vision for automated analysis of cells 
and tissues. Some of such works segment various cells from each image then extract features like 
size and shape from such cells. These extracted features are then used to train Machine Learning 
models or further analyzed by other Machine Vision algorithms. This include examples where 
they extract features from segmented blood cells and then classify them via Multilayer 
Perceptrons (Wei Lin et al., 1998). Other examples include grading of cervical intraepithelial 
neoplasia by extracting geometrical features that are analyzed using a combination of 
computerized digital image processing and Delaunay triangulation analysis (Keenan SJ, et al., 
2000). And localization of sub-cellular components via threshold adjacency statistics which are 
then analyzed by support vector machine (Hamilton NA et al., 2007). Others compare extracted 
features and raw pixel densities analyzed via Bayesian Classifier, K‐Nearest Neighbors, Support 
vector machine, and Random Forest (Timothy BL et al., 2016). Unlike all these works, we used 
Deep Learning in a End-to-End fashion, where we train our Convolutional Neural Network to 
directly analyze raw pixel values without any need for feature extraction. This drastically 
simplifies the process of developing automated Computer Vision systems for cell and tissue 
analysis. By eliminating feature extraction, Computer Vision system can then fully and truly learn 
important regularities pertaining cells themselves rather than being limited by rules via extracted 
features we create. 
 
Conclusion and Outlook 
  We developed a Convolutional Neural Network that accurately classifies MDA-MB-468 and 
MCF7 breast cancer cells after being trained on 995 brightfield breast cancer cell images, 
validated with 123 brightfield breast cancer cell images, and then tested on 123 brightfield breast 
cancer cell images. The Convolutional Neural Network performed well, with a 99% Accuracy score 
and 0.98 AUC score, indicating reliability for classification purposes. We believe that this system 
holds promise for expansion into other cancerous and normal cell lines of other diseases cases 
as may be reflected in upcoming work. More importantly it can potentially help lower barriers 
for care in less equipped labs. 
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